Do not takethe tablet with high calcium water, fruit juices, or other beverages. If you have any doubt about the potential high calcium levels of tap water (hard water), it is recommended to use bottled water with low mineral content.
-Swallow the tablet whole.Do not chew, crush, or dissolve it in your mouth.
-For the hour following (60 minutes)after taking the tablet:
-After waiting 1 hour, you can take breakfast and the first drink of the day. Once you have eaten, you can, if you wish, lie down and take any other medications you need.
Continuation of treatment withibandronate Aristo
It is essential to takeibandronate Aristoevery month, until your doctor tells you otherwise.
After 5 years of takingibandronateconsult with your doctor if you should continue takingthe medication.
If you take moreibandronate Aristothan you should
If you have taken, by mistake, some extra tablets,drink a full glass of milk and inform your doctor immediately.
Do not induce vomiting or lie downbecause you could irritate the esophagus.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to takeibandronate Aristo
If you forget to take the tablet in the morning of the day you have chosen,do not take the tablet later. Instead, check your calendar to see when your next dose is due:
If you forgot to take the tablet on your chosen day and your next dose is within 1 to 7 days...
Never take twoibandronate Aristotablets within the same week. Wait until it is time to take the next dose and take it as usual, then go back to taking one tablet a month according to the marked days on your calendar.
If you forgot to take the tablet on your chosen day and your next dose is more than 7 days...
Take a tablet the next morning after the day you remember forgetting the dose, then go back to taking one tablet a month according to the marked days on your calendar.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Inform your doctor or nurse immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
Rare(may affect up to 1 in 100 people):
?intense chest pain, intense pain when swallowing food or drink, intense nausea or vomiting, difficulty swallowing. You may have intense inflammation, possibly with a sensation of pain or constriction, in the throat/ tube through which food passes.
Uncommon(may affect up to 1 in 1,000 people):
?itching, swelling of the face, lips, tongue, and throat, with difficulty breathing.
?persistent eye pain and inflammation.
?new pain, weakness, or discomfort in the thigh, hip, or groin. These may be early symptoms of a possible unusual fracture of the thigh bone.
Very rare(may affect up to 1 in 10,000 people):
?pain or sensation of pain in the mouth or jaw. These may be early symptoms of serious jaw problems[bone necrosis (death of bone tissue) of the jawbone].
?severe allergic reaction that may pose a life-threatening risk.
Other possible side effects:
Common(may affect up to 1 in 10 people):
?headache
?heartburn, discomfort when swallowing, stomach pain or cramps (due to stomach inflammation), indigestion, nausea, diarrhea (intestinal losses)
?muscle cramps, joint stiffness and extremities
?flu-like symptoms, including fever, chills, and shivering, feeling unwell, bone, muscle, and joint pain. Consult your nurse or doctor if any effect becomes bothersome or lasts more than a couple of days
?skin rash.
Uncommon(may affect up to 1 in 100 people):
?dizziness
?flatulence (gas, feeling bloated)
?back pain
?sensation of fatigue and exhaustion
?asthma attacks.
?symptoms of low calcium levels in the blood (hypocalcemia), including muscle cramps or spasms and/or tingling sensation in the fingers or around the mouth.
Rare(may affect up to 1 in 1,000 people):
?inflammation of the duodenum (first section of the intestine) that causes stomach pain.
?Urticaria.
Reporting of side effects:
If you experience any type of side effect, consult your doctor or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use:
https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD.The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash.Deposit the packaging and unused medications at the SIGRE collection point of the pharmacy.In case of doubt, ask your pharmacist how to dispose of the packaging and unused medications.This will help protect the environment.
Composition of Aristo Ibandronic Acid
-The active ingredient is ibandronic acid. Each tablet contains 150 mg of ibandronic acid (in the form of sodium monohydrate).
-The other components are:
Tablet core: Povidone, microcrystalline cellulose, pregelatinized cornstarch, crospovidone, anhydrous colloidal silica, glicerol dibehenate.
Tablet coating: Opadry OY-LS-28908 (white II) composed of: hypromellose, lactose monohydrate, titanium dioxide (E171), macrogol 4000.
Appearance of the product and contents of the package
Aristo Ibandronic Acid tablets are white or off-white, round, and biconvex.
They are presented in carton containers containing 1 or 3 tablets conditioned in PA/Aluminum/PVC-aluminum laminate (alu-alu blister).
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Aristo Pharma Iberia, S.L.
C/Solana, 26
28850 Torrejón de Ardoz, Madrid
Spain
Responsible manufacturer
Pharmathen S.A.
6 Dervenakion Str.
153 51 Pallini, Attiki
Greece
Or
Pharmathen International S.A.
Sapes Industrial Park, Block 5
693 00 Rodopi
Greece
This medicine is authorized in the member states of the European Economic Area with the following names:
Denmark | Baxogar |
Italy | Baxogar |
Netherlands | Baxogar |
Portugal | Baxogar |
Spain | Ibandronic Acid Aristo 150 mg film-coated tablets |
Last review date of this leaflet: July 2023
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.